Nektar Therapeutics Asset Turnover Ratio (NKTR), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nektar Therapeutics  (NASDAQ: NKTR)
 

Nektar Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Nektar Therapeutics's asset turnover ratio sequentially decreased to 0.09 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 161 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2765 to 3053.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NKTR Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 442.34 % 205.19 % -5.45 % -1.53 % -39.68 %
Y / Y Revenue Change -9.34 % 3.83 % -25.25 % -51.13 % -52.42 %
Asset Turnover Ratio (TTM) 0.09 0.14 0.21 0.24 0.29
NKTR's Total Ranking # 3053 # 2765 # 2552 # 0 # 2402
Seq. Asset Change 43.48 % 172.2 % -5.27 % 46.6 % -19.26 %
Seq. Revenue Change -6.72 % -50.19 % 84.96 % 5.5 % 6.84 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 482
Overall Market # 3053

Asset Turnover Ratio Statistics
High Average Low
1.41 0.28 0.05
(Jun 30 2018)   (Jun 30 2019)




NKTR Company Profile • Back to NKTR Efficiency Comparisons • Compare NKTR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Sintx Technologies Inc   0.14 $ 1.330  Millions$ 9.778  Millions
Xencor Inc  0.13 $ 104.973  Millions$ 801.528  Millions
Lucid Diagnostics Inc   0.13 $ 5.445  Millions$ 41.667  Millions
Royalty Pharma Plc  0.13 $ 2,535.998  Millions$ 19,650.812  Millions
Omniab Inc   0.13 $ 38.457  Millions$ 298.628  Millions
Lineage Cell Therapeutics Inc   0.13 $ 13.083  Millions$ 104.494  Millions
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
Kura Oncology Inc   0.12 $ 77.225  Millions$ 657.022  Millions
Arcus Biosciences Inc   0.12 $ 117.000  Millions$ 1,008.500  Millions
Arcturus Therapeutics Holdings Inc   0.11 $ 29.368  Millions$ 255.803  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Surrozen Inc   0.11 $ 11.511  Millions$ 107.272  Millions
C4 Therapeutics Inc   0.11 $ 35.039  Millions$ 328.207  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Ginkgo Bioworks Holdings Inc   0.10 $ 111.863  Millions$ 1,082.996  Millions
Zymeworks Inc   0.09 $ 37.127  Millions$ 404.744  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Bolt Biotherapeutics Inc   0.09 $ 4.700  Millions$ 52.543  Millions
Bicycle Therapeutics Plc  0.09 $ 61.205  Millions$ 685.131  Millions
Therapeuticsmd Inc   0.09 $ 3.270  Millions$ 37.859  Millions
Lenz Therapeutics Inc   0.08 $ 21.475  Millions$ 256.428  Millions
Ocular Therapeutix Inc   0.08 $ 52.054  Millions$ 655.696  Millions
Agios Pharmaceuticals Inc   0.08 $ 98.338  Millions$ 1,244.086  Millions
Astrotech Corp  0.08 $ 1.701  Millions$ 21.727  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Longeveron Inc   0.08 $ 1.187  Millions$ 15.629  Millions
Armata Pharmaceuticals Inc   0.07 $ 6.034  Millions$ 81.537  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.